Clinical inputs
Understand the result,
not just the number.
Endomyocardial Biopsy Yield Predictor (Myocarditis Suspicion Model): Explanation and Clinical Context This calculator estimates the probability that an endomyocardial biopsy (EMB) will provide a specific histopathologic or immunohistochemical diagnosis in patients with clinically suspected myocarditis. Diagnostic yield in contemporary cohorts averages around 50–55%, depending on timing, imaging, sampling site, and targeting method. Clinical interpretation Early biopsy (≤14 days), positive cardiac MRI (updated Lake Louise Criteria), LV or biventricular sampling, electroanatomic mapping, and obtaining ≥5–7 specimens all substantially improve yield.
Delayed biopsy (>30 days) or right-ventricular-only sampling tends to reduce diagnostic return. The model assumes a baseline yield of 53% and applies incremental effects derived from published observational data. Use in practice Predicted yield <30% → low likelihood; optimize strategy before proceeding.
30–60% → intermediate yield; typical for most myocarditis biopsies. >60% → high yield; strategy optimized (early, LV/biventricular, mapping, adequate samples).
- Source 1
Duan X, et al. Diagnostic yield of updated indications for endomyocardial biopsy and prognostic impact.
- Source 2
(PMC) Martínez-Cossiani M, et al. Diagnostic yield and safety profile of EMB in the non-transplant setting. Eur Heart J.
- Source 3
Neves HAF, et al. Right or left EMB? Systematic review/meta-analysis about complications and safety. Int J Cardiol.
- Source 4
Casella M, et al. Electroanatomic voltage mapping to target EMB. JACC Cardiovasc Imaging.
- Source 5
ACC Expert Consensus Decision Pathway on Myocarditis. J Am Coll Cardiol.
- Source 6
Lagan J, et al. Contemporary CMR in suspected myocarditis. Circulation. 2023.
Loading discussion…